RNAZ - TransCode Therapeutics announces retirement of CEO
2024-01-12 16:11:44 ET
More on TransCode Therapeutics
- TransCode Therapeutics announces $1.2M registered direct offering of common stock
- TransCode shares plunge 20% on stock offering, Nasdaq compliance update
- Seeking Alpha’s Quant Rating on TransCode Therapeutics
For further details see:
TransCode Therapeutics announces retirement of CEO